Ticker

/PRNewswire/ -- USANewsGroup.com News Commentary - The global cell therapy manufacturing market is hitting a pivotal inflection point. It's projected to

KELOWNA, BC / ACCESS Newswire / March 17, 2026 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer of ultra-premium cannabis products, today announced that its wholly-owned subsidiary, GreenTec Holdings Ltd. ("GreenTec"), has issued a formal notice of termination for its Trademark Licensing Agreement with Adjupharm GmbH ("Adjupharm"), a subsidiary of IM Cannabis Corp.…

KELOWNA, BC / ACCESS Newswire / March 9, 2026 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), is pleased to announce that it has entered into a debt settlement agreement (the "Agreement") with an institutional investor (the "Creditor") to retire a significant portion of the Company's largest remaining debt obligation (the "Transaction"). The Transaction, which is expected to close…

/PRNewswire/ -- USANewsGroup.com News Commentary - The global cell therapy market is projected to surpass $8.2 billion in 2026, driven by a wave of clinical

LAS VEGAS, March 3, 2026 /PRNewswire/ -- Avaí Bio, Inc. (OTCQB: AVAI) ("Avaí" or the "Company"), an emerging biotechnology company developing transformative cell-based therapies for diabetes, age-related disorders, and anti-aging, today announced—together with its joint venture partner and global biotechnology firm, Austrianova—the initiation of production for a Master Cell Bank of genetically modified cells that…